- Investing Ideas
- /
- U.S. Potentially Undervalued Companies
U.S. Potentially Undervalued Companies
UPDATED Apr 16, 2024
Companies with a Value score of at least 3, ordered by Value score
6,201 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RMBS | US$58.72 | -4.5% | 18.6% | US$6.4b | US$76.96 | PE19x | E-13.3% | n/a | Semiconductors | ||
CANG | US$1.36 | -6.2% | 20.4% | US$192.2m | n/a | PB0.3x | n/a | 140.4% | Retail | ||
CAR | US$108.47 | -12.2% | -39.1% | US$4.0b | US$176.75 | PE2.4x | E-49.2% | n/a | Transportation | ||
ATLO | US$18.96 | -4.9% | -6.4% | US$170.9m | n/a | PB1x | n/a | 5.7% | Banks | ||
AKBA | US$1.40 | -9.1% | 105.2% | US$291.0m | US$5.00 | PS1.5x | E60.2% | n/a | Pharmaceuticals & Biotech | ||
ALG | US$212.74 | -4.5% | 18.7% | US$2.6b | US$230.50 | PE18.8x | E8.8% | 0.5% | Capital Goods | ||
ALXO | US$14.49 | 17.4% | 210.9% | US$646.5m | US$20.17 | PB3.8x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
ERJ | R$24.29 | -6.5% | 47.6% | R$23.1b | R$26.95 | PE29.5x | E32.5% | 0% | Capital Goods | ||
CPYY.Y | UK£6.47 | -1.3% | 14.7% | UK£6.9b | UK£8.57 | PE1.8x | E-41.4% | 3.1% | Utilities | ||
KOP | US$55.43 | -0.7% | 61.8% | US$1.2b | US$64.50 | PE13.2x | E9.9% | 0.5% | Materials | ||
JDDS.F | UK£1.57 | 0% | -28.0% | UK£6.1b | UK£2.20 | PE31.3x | E21.1% | 0.8% | Retail | ||
MARU.Y | JP¥172.38 | -2.0% | 18.9% | JP¥4.5t | JP¥182.80 | PE10x | E3.2% | 3.1% | Capital Goods | ||
PED | US$0.84 | 4.3% | -12.5% | US$75.1m | US$2.20 | PE284.3x | n/a | n/a | Energy | ||
GTN | US$5.53 | -6.7% | -33.1% | US$573.7m | US$10.42 | PB0.3x | E20.3% | 5.8% | Media | ||
GASN.Y | €4.57 | 5.3% | -25.0% | €20.7b | €5.15 | PE10.1x | E-9.7% | 6.7% | Utilities | ||
ISPC | US$0.21 | 0.7% | -86.9% | US$2.0m | US$3.00 | PB0.2x | E-10.0% | n/a | Healthcare | ||
CZOO | US$6.00 | -42.9% | -97.3% | US$36.2m | n/a | PE-0.05x | S11.9% | n/a | Retail | ||
STRA | US$96.71 | -6.8% | 5.3% | US$2.4b | US$120.50 | PE33.8x | E30.2% | 2.5% | Consumer Services | ||
GECF.F | €107.38 | 0% | 7.1% | €6.7b | €130.45 | PB0.6x | E104.0% | 5.8% | Real Estate | ||
NVEE | US$93.54 | -2.7% | -2.9% | US$1.5b | US$124.71 | PE33.4x | E12.4% | n/a | Commercial Services | ||
GGGS.Y | UK£11.93 | -2.1% | n/a | UK£2.8b | UK£13.74 | PE19.9x | E4.7% | 2.2% | Consumer Services | ||
DMTK | US$0.61 | -7.6% | -86.6% | US$21.5m | US$2.75 | PS1.4x | E17.6% | n/a | Pharmaceuticals & Biotech | ||
OPRT | US$2.19 | 2.3% | -43.2% | US$76.4m | US$3.50 | PB0.2x | E115.8% | n/a | Diversified Financials | ||
SEEM.F | UK£0.052 | -13.3% | -36.6% | UK£179.7m | n/a | PS4x | E114.1% | n/a | Tech |